ישראל - עברית - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - mesalazine (5 - aminosalicylic acid) 1 g - mesalazine

ישראל - עברית - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - mesalazine (5 - aminosalicylic acid) 1.5 g - mesalazine

ישראל - עברית - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - mesalazine (5 - aminosalicylic acid) 1.5 g - mesalazine

ישראל - עברית - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - mesalazine (5 - aminosalicylic acid) 3 g - mesalazine

ישראל - עברית - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - mesalazine (5 - aminosalicylic acid) 1 g - mesalazine

ישראל - עברית - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - mesalazine (5 - aminosalicylic acid) 1.5 g - mesalazine

ישראל - עברית - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - mesalazine (5 - aminosalicylic acid) 3 g - mesalazine

ישראל - עברית - Ministry of Health

megapharm ltd - glutamine - אבקה - glutamine 5 g/sachet - amino acids

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - live attenuated measles virus; live attenuated mumps virus; live attenuated rubella virus - אבקה וממס להכנת תמיסה להזרקה - live attenuated mumps virus 10^3.7 ccid50; live attenuated rubella virus 10^3.0 ccid50; live attenuated measles virus 10^3.0 ccid50 - rubella, combinations with mumps, live attenuated - rubella, combinations with mumps, live attenuated - priorix is indicated for active immunisation of children from the age of 9 months or older, adolescents and adults against measles, mumps and rubella.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; fillamentous haemagglutinin (fha); haemophilus influenzae type b polysaccharide; inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin; pertussis toxoid (pt); tetanus toxoid - אבקה ותרחיף להכנת תרחיף להזרקה - diphtheria toxoid nlt 60 iu/ml; inactivated polio virus (ipv) type 3 64 du / 1 ml; inactivated polio virus (ipv) type 2 16 du / 1 ml; inactivated polio virus (ipv) type 1 80 du / 1 ml; pertussis toxoid (pt) 50 mcg/ml; fillamentous haemagglutinin (fha) 50 mcg/ml; pertactin 16 mcg/ml; tetanus toxoid nlt 80 iu/ml; haemophilus influenzae type b polysaccharide 20 mcg/vial - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - active immunisation in infants from the age of 2 months to 5 years against diptheria, tetanus, pertussis, poliomyelitis and haemophilus influenza type b. booster dose for children who have previously been immunised with dtp, polio and hib antigens